ASKLEPIOS Course SYMPOSIUM ON IMAGING HALLMARKS OF CANCER. Education in partnership. October 18 19, 2018 Lisbon/Portugal. myesr.

Transcription

1 ON IMAGING HALLMARKS OF CANCER Education in partnership

2 Course information The Symposium is designed for scientist, radiologists, nuclear medicine physicians and other experts in cancer imaging interested in acquiring knowledge and sharing their expertise on cutting-edge methods to diagnose and manage cancer patients. On the first day of the Symposium, delegates will have the unique opportunity to learn from Patrick Bossuyt a renowned scientist and the professor of Clinical Epidemiology at the Academic Medical Center of the University of Amsterdam. Professor Bossuyt will address the evidence-based for rational decision-making about the use of medical tests and testing strategies in health care. The following day, an experienced multidisciplinary faculty will provide the delegates with a blend of novel experimental and clinical imaging methods used to diagnose cancer and improve cancer screening as well as to interrogate cancer biology and physiology.

3 Programme Thursday, October 18, :00 17:30 Registration 17:30 17:50 Welcome and introduction L. Beleza, Lisbon/PT President of the Champalimaud Foundation ESOR Representative C. Matos, Lisbon/PT Host organiser 18:00 18:30 Keynote lecture Chair: C. Matos, Lisbon/PT 18:30 19:00 Interlude Changes in the evaluation of medical tests: from results to consequences P. Bossuyt, Amsterdam/NL Imaging marine animals J.L Crespo, Valencia/ES Host Organiser C. Matos Lisbon/PT Venue Fundação Champalimaud Avenida Brasília, s/n Lisbon Portugal Registration information For information about the registration, please visit. For further information on the programme and registration please visit

4 Programme Friday, October 19, :00 10:30 Pre clinical MR imaging Chair: C. Matos, Lisbon/PT 10:30 11:00 Coffee break New strategies for probing malignancy and pre-metastatic niches at ultra-high field N. Shemesh, Lisbon/PT Mapping pre-metastatic niches using advanced DW MRI at ultra-high field R. Simoes, Lisbon/PT Mapping N-stages in colorectal cancer using multiexponential T2* I. Santiago, Lisbon/PT Mapping the pancreas in-vivo using spatially encoded MRI S. Gonçalves, Lisbon/PT 11:30 12:30 Radiomics Chair: N. Papanikolaou, Lisbon/PT 12:30 13:30 Lunch break Radiomics: what the radiologist needs to know L. Fournier, Paris/FR Radiomics: biological correlation and clinical challenges E. Sala, Cambridge/UK Building an imaging biobank in the era of radiomics E. Neri, Pisa/IT

5 Programme 13:30 15:00 Imaging strategies for improving cancer screening Chair: V. Vilgrain, Clichy/FR Breast cancer T. Helbich, Vienna/AT Lung cancer H.-U. Kauczor, Heildeberg/DE Colon cancer A. Laghi, Rome/IT Prostate cancer J. Futterer, Nijmegen/NL 15:00 15:30 Coffee break 15:30 17:00 Whole body MRI in clinical oncology: where are we now? Chair: F. Caseiro Alves, Coimbra/PT Metastatic bone disease F. Lecouvet, Brussels/BE Multiple myeloma S. Punwani, London/UK Lymphoma M. Mayerhöfer, Vienna/AT 17:00 18:00 Oncologic imaging: future perspectives Chair: L. Marti-Bonmati, Valencia/ES MR elastography to investigate cancer cell proliferation and metastases R. Sinkus, London/UK Mass spectrometry imaging for clinical research and cancer surgery R. Heeren, Maastricht/NL

6 Please note that programmes are marked with a logo to indicate their classification according to the European Training Curriculum. First three years of training Fourth and fifth year of training (general radiologist standard) Subspecialty training standard ESOR stands for education in partnership.